{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-24-036848","form_type":"8-K","ticker":"ELTX","cik":"0001601485","company_name":"Elicio Therapeutics, Inc.","filed_at":"2024-08-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.718900+00:00","generated_at":"2026-05-31T10:03:06.409704+00:00","sec_items":["1.01","2.03","3.02","8.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Elicio Therapeutics closes $20M convertible note private placement at $5.81 conversion price","bullets":["Raised $20M via 3% senior secured convertible note due Feb 2026; net proceeds ~$19.7M.","Conversion price $5.81 per share (~135% of Aug 9 close); subject to stockholder approval.","Purchaser GKCC LLC is controlled by a board member (related-party transaction).","Proceeds to be used for working capital and general corporate purposes.","Note is secured by first-priority lien on substantially all assets and intellectual property."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-24-036848","json":"https://secwatch.observer/filing/0001140361-24-036848.json","markdown":"https://secwatch.observer/filing/0001140361-24-036848.md","text":"https://secwatch.observer/filing/0001140361-24-036848.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1601485/000114036124036848/0001140361-24-036848-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1601485/000114036124036848/ef20033947_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T10:03:06.409704+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}